Parasites do not cause psoriasis in the way a virus causes the flu, but the relationship between parasites and psoriasis is far more tangled than a simple yes or no. Psoriasis is fundamentally a disease of the immune system attacking the skin, and parasites are among the most potent manipulators of the immune system that exist. Depending on the type of parasite, the timing of exposure, and the individual’s immune makeup, a parasitic infection might worsen psoriasis, mimic it so convincingly that doctors get the diagnosis wrong, or, in one of immunology’s more counterintuitive findings, actually help suppress it.
What Drives Psoriasis in the First Place
Psoriasis is not an infection. It is an autoimmune inflammatory disease in which the immune system attacks the body’s own skin cells. The central players are a type of immune cell called Th17 cells, which are stimulated by a signaling molecule called IL-23. In people with psoriasis, dendritic cells and skin cells overproduce IL-23, which drives Th17 cells to churn out inflammatory signals that accelerate skin cell growth to many times the normal rate. The result is the characteristic thick, scaly plaques.1PubMed Central. Pathophysiology of psoriasis: recent advances on IL-23 and Th17 cytokines
Because psoriasis is an immune-mediated disease, anything that shifts the immune system’s behavior has the potential to influence it. That includes infections, stress, medications, and yes, parasites. The question is not whether parasites “cause” psoriasis the way we think of causes in infectious disease. The question is whether parasites can tip an already susceptible immune system in one direction or another.
The Hygiene Hypothesis and the Parasite Paradox
One of the most influential ideas in modern immunology is the hygiene hypothesis, which proposes that growing up in an environment with fewer infections, particularly parasitic worm infections, leaves the immune system poorly calibrated. In populations that historically carried intestinal parasites for most of their lives, autoimmune diseases like psoriasis, inflammatory bowel disease, and multiple sclerosis were relatively rare. As sanitation improved and parasite burdens dropped, these conditions became far more common in industrialized countries.2PubMed. Parasites and the hygiene hypothesis: regulating the immune system?
The proposed mechanism is not that parasites prevent disease by keeping the immune system busy. It is more specific than that. Parasitic worms, known as helminths, actively suppress parts of the immune system to ensure their own survival inside the host. They stimulate regulatory immune cells that dial down the same inflammatory pathways responsible for autoimmune conditions. In mouse experiments, helminth infections have been shown to suppress both the Th1/Th17 responses that drive psoriasis and the Th2 responses that drive allergies.3Immunological Reviews. Induction of regulatory cells by helminth parasites: exploitation for the treatment of inflammatory diseases Some of this regulatory effect involves specialized immune cells called regulatory T cells, whose role has been demonstrated in parasite models in mice.4PubMed Central. The ‘hygiene hypothesis’ for autoimmune and allergic diseases: an update
The implication is striking: for some autoimmune conditions, including psoriasis, the absence of parasites may be part of the problem. That does not mean picking up a tapeworm is a treatment plan. But it does mean that the relationship between parasites and psoriasis runs in a direction most people would not expect.
Parasites That Coincide With Psoriasis
While the hygiene hypothesis focuses on the protective effects of certain worm infections, other parasites show up alongside psoriasis in ways that suggest a less friendly relationship. A study of 200 psoriasis patients found that about 42% had some form of parasitic infection. The most common was amoebiasis, found in roughly 30% of cases, followed by giardiasis at 19% and microfilaria at 9%. Hookworm, roundworm, and tapeworm infections were less common but still present.5Panacea Journal of Medical Sciences. Coexisting parasitic infestations in patients with psoriasis and effects of deworming therapy on response of treatment
Does that mean these gut parasites cause psoriasis? Not necessarily. The more likely explanation is that both psoriasis and parasitic infections are influenced by the same underlying immune environment, particularly the balance of pro-inflammatory and anti-inflammatory signals. What is more interesting is what happened when those patients were treated for their parasitic infections: the group that received deworming therapy alongside standard psoriasis treatment showed significantly greater improvement in their psoriasis severity scores compared to those who received psoriasis treatment alone.6Panacea Journal of Medical Sciences. Coexisting parasitic infestations in patients with psoriasis and effects of deworming therapy on response of treatment This is a single study, so the findings need replication, but it suggests that at least some gut parasites may amplify the inflammatory environment that makes psoriasis worse.
A separate area of investigation has looked at Toxoplasma gondii, the parasite commonly associated with cats. One study found that psoriasis patients had higher rates of past Toxoplasma exposure compared to controls, with about 64% of psoriasis patients testing positive for Toxoplasma antibodies versus 55% in a control group. The researchers suggested that the chronic low-grade immune activation from Toxoplasma infection might contribute to psoriasis susceptibility, though the study size was modest and the difference, while notable, is not definitive proof of causation.7Baghdad Science Journal. Incidence of Toxoplasmosis in Psoriasis Patients and Possible Correlation with Tumor Necrosis Factor-α
Scabies and the Skin-Level Trigger
Not all parasites work from the inside. Scabies, a skin infestation caused by the mite Sarcoptes scabiei, operates at the surface, burrowing into the epidermis and provoking intense immune reactions. Both scabies and psoriasis produce itchy, inflamed skin, and the two conditions share enough clinical features that they are sometimes confused for one another. Population-level data has found an increased risk of developing psoriasis after a scabies infection.8PubMed. Increased risk of psoriasis following scabies infection: A nationwide population-based matched-cohort study
The proposed mechanism involves something called the Koebner phenomenon, where psoriasis develops at sites of skin injury or irritation. Scabies mites create precisely the kind of sustained, localized skin damage that can trigger new psoriasis plaques in genetically susceptible people. The mite’s burrowing and the immune response to its feces and eggs produce a cocktail of inflammatory signals at the skin surface. In someone whose immune system already leans toward psoriatic inflammation, this is a nudge in the wrong direction. This makes scabies one of the more plausible external parasitic triggers for psoriasis, though again not a root cause in the way genetics and immune dysregulation are.
The Gut-Skin Axis
A growing body of research connects what happens in the gut to what shows up on the skin. The gut microbiome, the community of bacteria, fungi, and other organisms living in your intestinal tract, communicates with the immune system and influences inflammatory responses throughout the body. When the gut microbiome is disrupted, a condition known as dysbiosis, the resulting immune imbalance has been linked to skin conditions including psoriasis, rosacea, and atopic dermatitis.9PubMed Central. Gut-Skin Axis: Unravelling the Connection between the Gut Microbiome and Psoriasis
Intestinal parasites are powerful disruptors of the gut microbiome. They physically damage the intestinal lining, compete with resident bacteria, and alter immune signaling in ways that ripple outward. Whether that disruption worsens or improves psoriasis depends on the type of parasite. Gut dysbiosis in autoimmune disease is accompanied by an increase in pro-inflammatory Th17 cells, the same cell population that drives psoriasis.10PubMed Central. Both the microbiome and the macrobiome can influence immune responsiveness in psoriasis Some parasites push the microbiome toward greater inflammation; helminths, by contrast, tend to reshape the gut environment in ways that reduce it. The gut-skin axis helps explain why parasitic infections that seem distant from the skin can still influence what happens there.
Molecular Mimicry and Immune Confusion
One well-studied trigger for psoriasis is streptococcal throat infection, particularly in the form of guttate psoriasis that often appears in children and young adults after strep throat. The mechanism involves molecular mimicry: proteins on the surface of Streptococcus bacteria share structural similarities with proteins in human skin (keratin), causing the immune system to mistakenly attack skin cells after mounting a response to the bacteria.11PubMed. Psoriasis–as an autoimmune disease caused by molecular mimicry
Could parasites do something similar? In principle, molecular mimicry is not unique to bacteria. Many parasites produce surface proteins that resemble host proteins as a survival strategy, helping them evade the immune system. But there is no strong published evidence yet linking a specific parasite protein to cross-reactive immune attacks on human skin in the way that streptococcal M-protein has been linked to keratin-targeted T cells. The streptococcal connection remains the clearest example of infection-triggered psoriasis through mimicry, and it is a bacterial infection rather than a parasitic one. Whether any parasite generates a similar cross-reactive response in psoriasis remains an open question that researchers have not yet answered convincingly.
Helminth Therapy and Psoriasis
If certain parasites suppress the immune pathways that drive psoriasis, the obvious next question is whether you could use them as treatment. Researchers have been exploring this idea for over two decades, and while the field is still experimental, there are compelling early results. In one mouse model of psoriasis, treatment with a sugar molecule derived from a helminth (a glycan called LNFPIII) prevented the appearance of psoriasis-like skin lesions entirely. Treated mice maintained normal skin thickness, showed lower levels of the inflammatory cytokine interferon-gamma, and had restored immune cell populations compared to untreated mice with the same genetic predisposition.12PubMed. Prevention of psoriasis-like lesions development in fsn/fsn mice by helminth glycans
This is one of the clearest demonstrations that helminth-derived molecules can directly prevent psoriatic inflammation, at least in an animal model. The broader field of helminth therapy has explored live worm infections, secreted products from worms, and synthetic molecules based on worm-derived compounds across a range of autoimmune conditions including inflammatory bowel disease, multiple sclerosis, and type 1 diabetes.13PubMed Central. Helminth Immunomodulation in Autoimmune Disease Some of this work has progressed to clinical trials in humans, though the psoriasis-specific human trial data remains thin.
The appeal of helminth-derived therapies is that they target the regulatory arm of the immune system rather than simply suppressing it wholesale, the way many current psoriasis drugs do. Helminth products stimulate the body’s own anti-inflammatory machinery. Early-life exposure to helminths may be particularly important, as disruption of the immune balance during immune development appears to set the stage for inflammatory disorders later on.14PubMed Central. Coevolutionary interplay: Helminths-trained immunity and its impact on the rise of inflammatory diseases Researchers are now working to identify specific molecules from helminth secretions, including proteins, peptides, lipids, and RNA-carrying vesicles, that could be developed into drugs without requiring a patient to actually harbor a live worm.15PubMed Central. Therapeutic applicability of helminths in autoimmune diseases – literature overview
When Parasites Masquerade as Psoriasis
Sometimes what looks like psoriasis is not psoriasis at all. Cutaneous leishmaniasis, a skin disease caused by Leishmania parasites transmitted through sandfly bites, can produce scaly, crusted lesions on the scalp and skin that are clinically indistinguishable from psoriatic plaques. Case reports have documented patients treated for psoriasis for extended periods before a biopsy finally revealed Leishmania parasites in their skin tissue.16PubMed Central. Cutaneous leishmaniasis mimicking psoriasis: A case report
This matters because the treatments are completely different. Psoriasis is managed with immune-suppressing medications, while leishmaniasis requires antiparasitic drugs. Giving immunosuppressants to someone with an undiagnosed parasitic infection can make the infection dramatically worse. If you have skin lesions that were diagnosed as psoriasis but are not responding to treatment, especially if you have traveled to or live in a region where leishmaniasis is present (parts of the Middle East, Central and South Asia, North Africa, Central and South America), it is worth asking your doctor whether a biopsy should be done to rule out parasitic infection.
Psoriasis Drugs That Open the Door to Parasites
The relationship between parasites and psoriasis runs in both directions. Modern biologic drugs used to treat psoriasis work by suppressing specific immune pathways, particularly IL-17, IL-23, and TNF-alpha. These are the same pathways the body uses to fight off infections, including parasitic ones. Reports from tropical and subtropical settings have documented parasitic infections emerging in patients on biologic therapy for psoriasis. Cases of scabies, including severe crusted scabies, have been reported in patients taking biologics such as guselkumab, ustekinumab, and adalimumab.17PubMed Central. Infectious adverse events in patients treated with biotherapies in a tropical Amazonian context, French Guiana
In one case, cutaneous leishmaniasis developed in a patient with chronic psoriasis who was being treated with guselkumab, an IL-23 inhibitor. The lesion required a biopsy to diagnose because it appeared during the course of psoriasis management and could easily have been mistaken for a psoriasis flare.18Skin Health and Disease. A new association of cutaneous leishmaniasis with guselkumab in a patient with chronic psoriasis The risk of parasitic co-infection may be increased further when biologics are combined with corticosteroids or methotrexate, which compound the immunosuppressive effect.
For people living in or traveling to areas where parasitic infections are common, this is a practical concern. It does not mean biologics should be avoided. They are transformative treatments for severe psoriasis. But it does mean that unexplained new skin lesions, persistent itching in unusual patterns, or gastrointestinal symptoms during biologic therapy should prompt your doctor to consider parasitic infection as part of the workup, not just a psoriasis flare or drug side effect.
Why the Answer Resists a Simple Yes or No
Psoriasis is a genetically primed condition that requires environmental triggers to manifest. Those triggers are diverse: stress, throat infections, skin injuries, medications, and shifts in the immune environment. Parasites interact with nearly all of these pathways. Some parasites, like scabies mites, can act as direct triggers by damaging the skin and provoking local immune responses. Some gut parasites appear to co-exist with and potentially amplify psoriatic inflammation. And some parasites, particularly helminths, suppress the very immune circuits that drive psoriasis, raising the possibility that their absence from modern life is part of why psoriasis rates have climbed.
The honest scientific picture is that no parasite has been identified as a primary cause of psoriasis in the way that genetics and Th17-mediated inflammation have been. But parasites sit at some of the most important intersections of the immune system’s regulatory network, and their presence or absence can shift that network in ways that make psoriasis more or less likely. The research is still catching up to the complexity. Most of the strongest evidence, particularly for helminth-based therapies, comes from animal models and small human studies. Large randomized trials specifically testing helminth products in psoriasis patients are still needed. For now, the clearest practical takeaway is that if you have psoriasis, parasitic infections should be screened for and treated, because co-existing gut parasites may be undermining your treatment response, and if you are on biologic therapy, new or unusual symptoms deserve a broader diagnostic lens than psoriasis alone.